These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 223567)

  • 21. Inhibition of Neisseria gonorrhoeae by sodium polyanetholesulfonate.
    Staneck JL; Vincent S
    J Clin Microbiol; 1981 Mar; 13(3):463-7. PubMed ID: 6263942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiological inhibitors of thrombin and thrombin synthesis].
    Schröer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):212-22. PubMed ID: 4122964
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of thrombin, plasmin, thrombin-antithrombin III complex and plasmin-antithrombin III complex with isolated hepatocytes.
    Spolarics Z; Kalapos MP; Léránt I; Garzó T; Antoni F; Mandl J; Machovich R
    Biochim Biophys Acta; 1989 Aug; 1012(3):231-6. PubMed ID: 2547438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of thermodynamic nonideality in kinetic studies: evidence of an expanded intermediate complex in the inactivation of thrombin by antithrombin III.
    Hogg PJ; Jackson CM; Winzor DJ
    Biochim Biophys Acta; 1991 Apr; 1073(3):609-13. PubMed ID: 2015284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium polyanethol sulfonate inactivation of aminoglycosides.
    Krogstad DJ; Murray PR; Granich GG; Niles AC; Ladenson JH; Davis JE
    Antimicrob Agents Chemother; 1981 Aug; 20(2):272-4. PubMed ID: 6169306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 37. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction and thermal stability of fluorescent labeled derivatives of thrombin and antithrombin III.
    Atha DH; Brew SA; Ingham KC
    Biochim Biophys Acta; 1984 Feb; 785(1-2):1-6. PubMed ID: 6696918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.
    Preissner KT; Zwicker L; Müller-Berghaus G
    Biochem J; 1987 Apr; 243(1):105-11. PubMed ID: 3606566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.